Roos J - Search Results

1

Matching-adjusted indirect comparison of Acalabrutinib versus Ibrutinib in relapsed/refractory mantle cell lymphoma.

Cai L, Roos J, Miranda PAP, Liljas B, Rule S, Wang M. Cai L, et al. Among authors: roos j. J Med Econ. 2024 Oct 26:1-8. doi: 10.1080/13696998.2024.2422227. Online ahead of print. J Med Econ. 2024. PMID: 39461001 Free article.

2

Quality-adjusted survival time without symptoms or toxicity of acalabrutinib with or without obinutuzumab in patients with treatment-naive chronic lymphocytic leukemia.

Sharman JP, Miranda P, Roos J, Emeribe U, Cai L, Liljas B, Gaitonde P. Sharman JP, et al. Among authors: roos j. Leuk Lymphoma. 2023 Jul-Aug;64(7):1243-1252. doi: 10.1080/10428194.2023.2212433. Epub 2023 May 23. Leuk Lymphoma. 2023. PMID: 37221877

3

Cumulative review of hypertension in patients with chronic lymphocytic leukemia treated with acalabrutinib.

Ferrajoli A, Follows G, Marmor Y, Roos J, Bajwa N, Madhira V, Nozaki K, Miranda P, Pennap D, Patel K. Ferrajoli A, et al. Among authors: roos j. Haematologica. 2024 Nov 7. doi: 10.3324/haematol.2024.285757. Online ahead of print. Haematologica. 2024. PMID: 39506916 Free article.

4

A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia.

Kittai AS, Skarbnik A, Miranda M, Yong ASM, Roos J, Hettle R, Palazuelos-Munoz S, Shetty V, Ghia P. Kittai AS, et al. Among authors: roos j. Am J Hematol. 2023 Dec;98(12):E387-E390. doi: 10.1002/ajh.27110. Epub 2023 Oct 9. Am J Hematol. 2023. PMID: 37811799 No abstract available.

5

An indirect comparison of acalabrutinib with and without obinutuzumab vs zanubrutinib in treatment-naive CLL.

Kittai AS, Allan JN, James D, Bridge H, Miranda M, Yong ASM, Fam F, Roos J, Shetty V, Skarbnik A, Davids MS. Kittai AS, et al. Among authors: roos j. Blood Adv. 2024 Jun 11;8(11):2861-2869. doi: 10.1182/bloodadvances.2023012142. Blood Adv. 2024. PMID: 38598745 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 39112306

7

Decoding the Digital Pulse: Bibliometric Analysis of 25 Years in Digital Health Research Through the Journal of Medical Internet Research.

Kaczmarczyk R, Wilhelm TI, Roos J, Martin R. Kaczmarczyk R, et al. Among authors: roos j. J Med Internet Res. 2024 Nov 15;26:e60057. doi: 10.2196/60057. J Med Internet Res. 2024. PMID: 39546778 Free PMC article.

8

Open sternal fracture with bilateral dislocation of the sternoclavicular joints after a high-speed bicycle accident: a case report.

Prangenberg C, Zellner AA, Roos J, Zalepugas D, Ossendorff R, Ben Amar S, Cucchi D, Scheidt S. Prangenberg C, et al. Among authors: roos j. J Med Case Rep. 2024 Nov 10;18(1):528. doi: 10.1186/s13256-024-04877-6. J Med Case Rep. 2024. PMID: 39522043 Free PMC article. Review.

9

MRI Dixon Fat-Corrected Look-Locker T1 Mapping for Quantification of Liver Fibrosis and Inflammation-A Comparison With the Non-Fat-Corrected Shortened Modified Look-Locker Inversion Recovery Technique.

Klaus JB, Goerke U, Klarhöfer M, Keerthivasan MB, Jung B, Berzigotti A, Ebner L, Roos J, Christe A, Obmann VC, Huber AT. Klaus JB, et al. Among authors: roos j. Invest Radiol. 2024 Nov 1;59(11):754-760. doi: 10.1097/RLI.0000000000001084. Invest Radiol. 2024. PMID: 39514773 Free PMC article.

10

Nitro-fatty acids: promising agents for the development of new cancer therapeutics.

Roos J, Manolikakes G, Schlomann U, Klinke A, Schopfer FJ, Neumann CA, Maier TJ. Roos J, et al. Trends Pharmacol Sci. 2024 Nov;45(11):1061-1080. doi: 10.1016/j.tips.2024.09.009. Epub 2024 Oct 25. Trends Pharmacol Sci. 2024. PMID: 39490362 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

973 results

Search Page

Filters